SOPHiA GENETICS SA (90B)
XSTU
Closed
Aug 25, 2026
Day's Range
7.1052 wk Range
2.62Overview - 90B - SOPHiA GENETICS SA
Key Statistics
Valuation
Enterprise Value
485.62M
P/E (Trailing)
‪-6.11‬
PEG Ratio
‪0.67‬
Price / Sales (TTM)
‪7.11‬
Price / Book
‪8.61‬
EV / EBITDA
‪-7.90‬
Profitability
Gross Margin
‪64.61%‬
Profit Margin
‪-93.86%‬
Operating Margin
‪-86.02%‬
Return on Assets
‪-24.51%‬
Return on Equity
‪-101.21%‬
Ownership
Shares Outstanding
83.89M
Float
65.31M
Held by Insiders
‪6.83%‬
Held by Institutions
‪62.23%‬
Price stats
Beta
‪0.92‬
50-Day Avg
‪5.33‬
200-Day Avg
‪4.42‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 90B - SOPHiA GENETICS SA
Peers - 90B - SOPHiA GENETICS SA
Peer Comparison
Compared with companies in Health Information Services listed on XSTU.
Profile Summary - 90B - SOPHiA GENETICS SA
About
Sophia Genetics SA is a global leader in data-driven medicine focused on enabling healthcare institutions to leverage artificial intelligence and data analytics to enhance clinical diagnosis. The company's main purpose is to democratize data-driven medicine, making genomic and other types of patient data insights…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
